PROXEON BIOSYSTEMS ApS
Nøgletal
- Afkastningsgrad
- -0,1 %
- Egenkapitalforrentning
- 0,8 %
- Likviditetsgrad
- 40.327,9 %
- Soliditetsgrad
- 99,8 %
Resultat
| Regnskabsperiode | |
|---|---|
Bruttoresultat | 0 |
Driftsresultat | -279.000 |
Finansielle indtægter | 4.398.000 |
Finansielle omkostninger | 288.000 |
Skat af årets resultat | 881.000 |
Årets resultat | 2.950.000 |
Medarbejdere
| Regnskabsperiode | |
|---|---|
Gns. ansatte | 0 |
Balance
| Regnskabsperiode | |
|---|---|
Kortfristede aktiver | 387.551.000 |
Aktiver i alt | 387.551.000 |
Egenkapital | 386.590.000 |
Forpligtelser i alt | 961.000 |
Kortfristede forpligtelser | 961.000 |
Arbejdskapital
| Regnskabsperiode | |
|---|---|
Andre kortfristede tilgodehavender | 69.000 |
Leverandørgæld | 80.000 |
Kapital og udbytte
| Regnskabsperiode | |
|---|---|
Selskabskapital | 4.000.000 |
Overført resultat | 382.590.000 |
Foreslået udbytte | 0 |
Højdepunkter fra årsrapporten
Forretning og udvikling
The Company has no operating activities. The key activity is to provide financing to Group related parties.
Risici og væsentlige forhold
No events materially affecting the assessment of the Annual Report have occurred after the balance sheet date.
Forpligtelser og sikkerhedsstillelser
Other contingent liabilities
There are no security and contingent liabilities at 31 December 2025.
The Danish group companies are jointly and severally liable for tax on the jointly taxed income of the Group. The total amount of corporation tax payable is disclosed in the Annual Report of Nunc A/S, which is the management company of the joint taxation purposes. Moreover, the group companies are jointly and severally liable for Danish withholding taxes by way of dividend tax, tax on royalty payments and tax on unearned income. Any subsequent adjustments of corporation taxes and withholding taxes may increase the Company's liability.
Se op til 9 års regnskabshistorik ved at oprette en gratis bruger
Opret gratis bruger